A chromatographically purified human TGF-β1 fraction from virally inactivated platelet lysates

Vox Sanguinis

Volumn 101, Issue 3, 2011, Pages 215-220

  Burnouf, T ^a,b   Chang, C W ^b,c   Kuo, Y P ^d   Wu, Y W ^d   Tseng, Y H ^e   Su, C Y ^f  

^a HUMAN PROTEIN PROCESS SCIENCES   (France)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Gwo Rei Biomedical Technology Group   (Taiwan)

^e Gwo Wei Dental Implant Center   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chondrogenesis; Fractionation; Osteogenesis; Platelet; Solvent detergent; TGF 1

Indexed keywords

ALBUMIN; CHOLESTEROL; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLATELET DERIVED GROWTH FACTOR AB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; VASCULOTROPIN;

APHERESIS; ARTICLE; CHONDROGENESIS; CHROMATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIPID ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; THROMBOCYTE;

BLOOD PLATELETS; CHROMATOGRAPHY, ION EXCHANGE; CYTOKINES; HUMANS; IMMUNOGLOBULINS; OCTOXYNOL; TRANSFORMING GROWTH FACTOR BETA1; VIRUS INACTIVATION;

EID: 80052933634     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01486.x     Document Type: Article

References (42)

1. Barrientos S, Stojadinovic O, Golinko MS, et al.: Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16:585-601
2. Ehnert S, Baur J, Schmitt A, et al.: TGF-b(1) as possible link between loss of bone mineral density and chronic inflammation. PLoS ONE 2010; 5:e14073
3. Schliephake H: Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002; 31:469-484
4. Lind M: Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl 1998; 283:2-37
5. Robey PG, Young MF, Flanders KC, et al.: Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 1987; 105:457-463
6. Johnstone B, Hering TM, Caplan AI, et al.: In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238:265-272
7. Thorpe SD, Buckley CT, Vinardell T, et al.: The response of bone marrow-derived mesenchymal stem cells to dynamic compression following TGF-beta 3 induced chondrogenic differentiation. Ann Biomed Eng 2010; 38:2896-2909
8. Iwasaki M, Nakata K, Nakahara H, et al.: Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology 1993; 132:1603-1608
9. Vinatier C, Mrugala D, Jorgensen C, et al.: Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009; 27:307-314
10. Schliephake H: Application of bone growth factors - the potential of different carrier systems. Oral Maxillofac Surg 2010; 14:17-22
11. Fujii S, Maeda H, Tomokiyo A, et al.: Effects of TGF-beta1 on the proliferation and differentiation of human periodontal ligament cells and a human periodontal ligament stem/progenitor cell line. Cell Tissue Res 2010; 342:233-242
12. Capron C, Lacout C, Lecluse Y, et al.: A major role of TGF-beta1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood 2010; 116:1244-1253
13. Mueller MB, Fischer M, Zellner J, et al.: Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 2010; 192:158-166
14. Watabe T, Miyazono K: Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009; 19:103-115
15. Borzini P, Mazzucco L: Platelet gels and releasates. Curr Opin Hematol 2005; 12:473-479
16. Weibrich G, Kleis WK, Hafner G, et al.: Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002; 30:97-102
17. Weibrich G, Kleis WK, Kunz-Kostomanolakis M, et al.: Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillofac Implants 2001; 16:693-699
18. Mazzucco L, Balbo V, Cattana E, et al.: Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009; 97:110-118
19. Everts PA, Brown Mahoney C, Hoffmann JJ, et al.: Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006; 24:165-171
20. Kuo YP, Lee YL, Tseng YH, et al.: Influence of ethanol on the release of growth factors in human blood-derived platelet gels. Biologicals 2010; 38:120-127
21. Martineau I, Lacoste E, Gagnon G: Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Biomaterials 2004; 25:4489-4502
22. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, et al.: Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009; 27:63-69
23. Bessa PC, Casal M, Reis RL: Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008; 2:81-96
24. Su CY, Kuo YP, Lin YC, et al.: A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sang 2009; 97:119-128
25. Burnouf T, Tseng YH, Kuo YP, et al.: Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 2008; 48:1090-1098
26. Burnouf T, Kuo YP, Huang CT, et al.: A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets. Transfusion 2010; 50:1702-1711
27. Burnouf T, Goubran HA, Radosevich M, et al.: A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Transfusion 2006; 46:2100-2108
28. Michalski C, Bal F, Burnouf T, et al.: Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma. Vox Sang 1988; 55:202-210
29. Su CY, Kuo YP, Nieh HL, et al.: Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008; 48:2414-2420
30. Maguire PB, Fitzgerald DJ: Platelet proteomics. J Thromb Haemost 2003; 1:1593-1601
31. Zimmermann G, Henle P, Kusswetter M, et al.: TGF-beta1 as a marker of delayed fracture healing. Bone 2005; 36:779-785
32. Garrison KR, Shemilt I, Donell S, et al.: Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev 2010; CD006950
33. Bieback K, Hecker A, Kocaomer A, et al.: Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009; 27:2331-2341
34. Kocaoemer A, Kern S, Kluter H, et al.: Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007; 25:1270-1278
35. Strunk D, Schallmoser K: Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp 2009; e1523
36. Doucet C, Ernou I, Zhang Y, et al.: Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005; 205:228-236
37. Shih DTB, Chen JC, Chen WY, et al.: Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 2010; doi.
38. Bikle DD, Harris J, Halloran BP, et al.: Expression of the genes for insulin-like growth factors and their receptors in bone during skeletal growth. Am J Physiol 1994; 267:E278-E286
39. Dichtelmuller HO, Biesert L, Fabbrizzi F, et al.: Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009; 49:1931-1943
40. Horowitz B, Prince AM, Horowitz MS, et al.: Viral safety of solvent-detergent treated blood products. Dev Biol Stand 1993; 81:147-161
41. Klein HG: Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005; 257:224-237
42. Burnouf T, Radosevich M: Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000; 14:94-110